← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2017-09-06
Drug application
- FDA Application #
ANDA205529- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- OXALIPLATIN
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- EUGIA PHARMA
- Manufacturer
- Eugia US LLC
- First approval
- 2017-09-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown